Cellectar Biosciences Stock (NASDAQ: CLRB) stock price, news, charts, stock research, profile.
Open | $2.11 |
Close | $2.07 |
Volume / Avg. | 238.38K / 550.66K |
Day Range | $2.03 - $2.11 |
52 Wk Range | 1.82 - 4.45 |
Market Cap | $74.21M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 8.13% |
Days to Cover | 10.52 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cellectar Biosciences (NASDAQ:CLRB) through any online brokerage.
Other companies in Cellectar Biosciences’s space includes: Renovaro (NASDAQ:RENB), Connect Biopharma Hldgs (NASDAQ:CNTB), Immuneering (NASDAQ:IMRX), Armata Pharmaceuticals (AMEX:ARMP) and Gritstone Bio (NASDAQ:GRTS).
There is no analysis for Cellectar Biosciences to provide a consensus price target.
The stock price for Cellectar Biosciences (NASDAQ: CLRB) is $2.07 last updated September 20, 2024 at 4:27 PM EDT.
There are no upcoming dividends for Cellectar Biosciences.
Cellectar Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Cellectar Biosciences.
Cellectar Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.